Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00485966 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
25
Enrollment
INDUSTRY
Sponsor class

Stopped This study was withdrawn prior to patient enrollment

Conditions

Interventions

Sponsor

Cylene Pharmaceuticals